Clinical trials in Pontevedra – page 5

65 clinical trials in Pontevedra, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Pontevedra at a glance

clinical trials

Research sites0

Quick filters

65 trials in Pontevedra

Open in trial search

Hidradenitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
Sponsor:Incyte Corp.

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Spain

Participants:18–64 years
Substances:Golimumab
Sponsor:Janssen - Cilag International

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Brodalumab
Sponsor:LEO PHARMA A/S

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

InvestigationalNo placebo

Spain

Participants:18–64 years
Substances:Upadacitinib
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Colorectal cancer metastatic+1

Not recruiting

Registered drugNo placebo

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tinzaparin Sodium
Sponsor:Grupo Gallego De Investigacion En Tumores Digestivos

Contact Research Centre

Pulmonary tuberculosis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Cyanocobalamin
Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Contact Research Centre

End stage renal disease+1

Not recruiting

Registered drugNo placebo

Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Isoniazid
Sponsor:Bellvitge University Hospital

Contact Research Centre

Anal fistula

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn's Disease and Complex Perianal Fistulas

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Chronic hepatitis B+1

Not recruiting

Investigational

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Bepirovirsen
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
Sponsor:Incyte Corp.

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Obefazimod
Sponsor:Abivax

Contact Research Centre

Portal hypertension

Not recruiting

Registered drugNo placebo

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bi 685509
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Pontevedra

What the registry says about research in the country

01 Infectious Diseases

Clinical studies focusing on tuberculosis treatments, including innovative approaches for both latent and active forms of the disease in special patient populations.

Pulmonary tuberculosis treatment optimization
Latent TB in kidney disease patients
Novel drug combinations

Research evaluating the effectiveness of various rifamycin-based regimens and high-dose antibiotic combinations.

02 Hepatology

Extensive research into liver diseases, particularly focusing on non-alcoholic steatohepatitis (NASH) and chronic hepatitis B treatments.

NASH therapy development
Chronic hepatitis B management
Liver fibrosis treatment

Multiple studies evaluating novel therapeutic approaches and combination treatments for liver conditions.

03 Dermatology & Immunology

Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis and urticaria.

Atopic dermatitis treatment
Chronic urticaria management
Hidradenitis suppurativa therapy

Investigation of new targeted therapies and dose optimization studies for various skin conditions.

Back to Spain All countries